In cerebrospinal fluid ER chaperones ERp57 and calreticulin bind β-amyloid

被引:77
作者
Erickson, RR
Dunning, LM
Olson, DA
Cohen, SJ
Davis, AT
Wood, WG
Kratzke, RA
Holtzman, JL
机构
[1] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Anesthesia, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Dept Environm Hlth Sci, Minneapolis, MN 55455 USA
[5] Reg Med Ctr, Dept Lab Serv, St Paul, MN USA
[6] VA Med Ctr, Dept Res, Minneapolis, MN USA
[7] VA Med Ctr, Dept Anesthesia, Minneapolis, MN USA
[8] VA Med Ctr, Dept Med Serv, Minneapolis, MN USA
[9] VA Med Ctr, Dept Geriatr Res, Educ & Clin Ctr, Minneapolis, MN USA
关键词
Alzheimer's disease; dementia; beta-amyloids; ERp57; calreticulin; posttranslational protein processing;
D O I
10.1016/j.bbrc.2005.04.090
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The beta-amyloids (abetas) are the major components of the plaque observed in the brains of patients with Alzheimer's disease. The conundrum is that although they are produced in everyone during the posttranslational processing in the endoplasmic reticulum (ER) of the amyloid precursor protein (APP), deposits are only observed in the elderly. Our work suggests that normals have a carrier protein(s) keeping them in solution. Based on immunoblotting studies of cerebrospinal fluid (CSF) from normals, we find that the bulk of the abetas are bound to the ER chaperones, ERp57 and calreticulin, suggesting that these may be carrier proteins which prevent aggregation of the abetas and that the deposits are due to faulty ER posttranslational processing of APP with the failure to form this complex. If membrane protein synthesis is similarly affected, it could explain the neuronal dysfunction characteristic of Alzheimer's disease. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:50 / 57
页数:8
相关论文
共 46 条
[1]
Avdulov NA, 1997, J NEUROCHEM, V69, P1746
[2]
BERG RA, 1979, J BIOL CHEM, V254, P3111
[3]
IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA [J].
Calfon, M ;
Zeng, HQ ;
Urano, F ;
Till, JH ;
Hubbard, SR ;
Harding, HP ;
Clark, SG ;
Ron, D .
NATURE, 2002, 415 (6867) :92-96
[4]
Progressive reduction of synaptophysin message in single neurons in Alzheimer disease [J].
Callahan, LM ;
Vaules, WA ;
Coleman, PD .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (05) :384-395
[5]
Evidence that casein kinase 2 phosphorylates hepatic microsomal calcium-binding proteins 1 and 2 but not 3 [J].
Chen, NQ ;
Davis, AT ;
Canbulat, EC ;
Liu, YX ;
Goueli, S ;
McKenzie, BA ;
Eccleston, ED ;
Ahmed, K ;
Holtzman, JL .
BIOCHEMISTRY, 1996, 35 (25) :8299-8306
[6]
ER quality control: towards an understanding at the molecular level [J].
Ellgaard, L ;
Helenius, A .
CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (04) :431-437
[7]
The thiol-dependent reductase ERp57 interacts specifically with N-glycosylated integral membrane proteins [J].
Elliott, JG ;
Oliver, JD ;
High, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (21) :13849-13855
[8]
Regulation of internal ribosomal entry site-mediated translation by phosphorylation of the translation initiation factor eIF2α [J].
Fernandez, J ;
Yaman, I ;
Sarnow, P ;
Snider, MD ;
Hatzoglou, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (21) :19198-19205
[9]
TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-domain [J].
Frickel, EM ;
Riek, R ;
Jelesarov, I ;
Helenius, A ;
Wüthrich, K ;
Ellgaard, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :1954-1959
[10]
GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027